Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.


Export to Word (
Principal Investigator: Athar, Mohammad
Institute Receiving Award University Of Alabama At Birmingham
Location Birmingham, AL
Grant Number R01ES026219
Funding Organization National Institute of Environmental Health Sciences
Award Funding Period 01 Jul 2016 to 30 Jun 2021
DESCRIPTION (provided by applicant): Non-melanoma skin cancers (NMSCs), which include both basal cell (BCCs) and squamous cell carcinomas (SCCs), are the most common skin neoplasm. Environmental ultraviolet B (UVB) exposure is the main etiologic factor for these skin cancers. However, other environmental and genetic factors also affect their susceptibility. In organ transplant recipients (OTRs) the incidence of these cancers increases by 10 to 250 fold. In addition, these tumors become more aggressive/invasive and metastatic ultimately contributing to augmented morbidity and mortality in this already morbid population. These cancers in OTRs are not only originated from the carcinogenic exposure of the transplant recipient but may also be contributed by the donor organ. Circulating tumor cells have also been found in these patients. At present at least 500,000 OTRs are living in the USA and their number is growing every year. Skin cancer is the most frequently occurring neoplasm in this population. Therefore, prevention of skin cancer is desperately required in this population. Oral retinoid showed some success in this regard however, their administration cause severe toxicity particularly hyperlipidemia. Here at the University of Alabama at Birmingham, we have developed a relatively non-toxic retinoid without compromising its efficacy. UAB30, a 9-cis retinoic acid was found to be well-tolerated in humans and in experimental animals and showed no significant toxicity as compared to placebo group. We, therefore propose here to test the hypothesis that UAB30 may be highly effective in preventing BCCs and SCCs in chronically immuno-suppressed mice and acts by inducing DNA damage response (DDR) signaling besides activating RAR/RXR pathway. For this, we have developed novel genetically engineered Ptch1+/-/SKH-1 mice, which following chronic UVB irradiation, develop both BCCs and SCCs. We also have compelling preliminary data to support our hypothesis. Three specific aims are proposed. Specific Aim 1 will investigate the effects of UAB30 on development of BCCs/SCCs in chronically immuno-suppressed UVB-irradiated Ptch1+/-/SKH-1 mice. Specific Aim 2 will investigate the molecular mechanisms by which UAB30 mediates skin cancer prevention. In preliminary studies, we found that UAB30 induces DDR signaling. We will therefore assess whether these responses are identical in immuno-competent and immuno-suppressed animals. Specific Aim 3 will unravel the molecular basis for the pharmacological action of UAB30 in the experiment settings of normal and immuno- suppression using in vitro/in vivo approaches. We will study whether alterations fanconi anemia DNA damage repair pathway are important mechanistic component underlying efficacy of UAB30. In summary, studies proposed here will not only demonstrate the preclinical efficacy of UAB30 in chronically immuno-suppressed mice but will also address its molecular mechanism dependent/independent of RAR/RXR.
Science Code(s)/Area of Science(s) Primary: 58 - Skin
Publications See publications associated with this Grant.
Program Officer Michael Humble
to Top